Trial record 1 of 5 for:    VAL--083
Previous Study | Return to List | Next Study

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by DelMar Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
DelMar Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01478178
First received: November 14, 2011
Last updated: September 25, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)